TAVI with Evolut R device in low risk patients

Live Case Broadcasted by TBR Productions from Toulouse, France to Rio de Janeiro, Brazil, where took place the SOLACI-SBHCI 2016 Congress.

Panelists: Rafael Cavalcante e Silva – BRAZIL, Patrick W. Serruys – UK, Samir Kapadia – USA, Jorge Atilio Belardi – ARGENTINA.

More articles by this author

Bringing More MIL / MINT to Light Through CLIMB Grants – Check out our educational event again

You can now relive our virtual event on "Bringing More MIL / MINT to Light Through CLIMB Grants", held last May 2 on our...

The Visible Heart Lab – Rewatch now our event on coronary bifurcations

You can now relive our virtual event on “The Visible Heart Lab” on Forks, held in conjunction with Medtronic. The event was held on April...

Challenging Borders and Advancing Together: Women at the Forefront of Hemodynamics – Watch again our webinar

You can now relive our virtual event on "Defying borders and moving forward together: women at the forefront in hemodynamics" on our YouTube channel. The...

Watch Again the Turning Point on the Treatment of HTN

You can now relive our virtual event on The turning point in the treatment of HTN on our YouTube channel. The event took place last...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

1-Year Outcomes of US TAVR Registry with 5th Generation Balloon Expandable Valves

The use of transcatheter aortic valve replacement (TAVR) has extended to younger patients with lower risk severe aortic stenosis (AS) and therefore the improvement...

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...